Search
Patexia Research
Case number IPR2022-01226

Mylan Pharmaceuticals Inc. et al. v. Regeneron Pharmaceuticals, Inc. > Summary

Court Case Number IPR2022-01226

Filing Date Jul 1, 2022

Institution Decision Date Jan 11, 2023

Decision Date Jan 9, 2024

Court Patent Trial and Appeal Board

Status Final Written Decision - Appeale

Appeal2024-1567

Administrative JudgesJohn G. New, Susan L. C. Mitchell, Robert A. Pollock

Judge Writing the Final DecisionJohn G. New

Claims Challenged in the Petition: 1, 2, 5, 6, 7, 8, 9, 34, 35, 36, 37, 38, 39, 41, 42, 43, 45

Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9, 34, 35, 36, 37, 38, 39, 41, 42, 43, 45

Claims Invalidated: 1, 2, 3, 4, 5, 6, 7, 8, 9, 34, 35, 36, 37, 38, 39, 41, 42, 43, 45

Petitioner

Related Patents

Doc No Title Issue date
10888601 Use of a VEGF antagonist to treat angiogenic eye disorders Jan 12, 2021
Menu